ClinicalTrials.gg
RecruitingNCT06836830PerAVentUpdated Aug 6, 2025

PEEP vs. ZEEP in Out-of-Hospital-Cardiac-Arrest

An interventional study of PEEP 5 mbar and ZEEP 0 mbar in Ventilation Therapy, PEEP, Occult and CPR, sponsored by Muehlenkreiskliniken, MKK. Recruiting at 3 sites in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-06.

Sponsored by Muehlenkreiskliniken, MKK · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Jun 2025; still recruiting 1 year 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
600
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 38 studies in Heart Arrest with a site in Germany — 8 open to participants now, 10 under way, none of them phase 3. Heart Arrest · Germany.

Planned enrollment
4th of 23
600 · median 150
Started
2025
with 2 others
No phase
18 of 38
4 open now
Registered
34th of 38
by date

Among the 38 studies in Heart Arrest with a site in Germany, this one is the 4th largest by planned enrollment of the 23 interventional ones that give a count, is one of 3 that started in 2025, is one of 18 with no phase, and was the 34th registered.

Heart Arrest

927 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.

Browse Heart Arrest studies →

Open to participants now

8 of the 38 studies in Heart Arrest with a site in Germany are open now. Recruiting first, the newest first:

2 more — sign in →

All 8 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 157 Heart Arrest studies recruiting now, 109 (69%) set no upper age limit and 28 (18%) stop at 75 or younger; 30 take children under 18; 18 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 38 studies in Heart Arrest with a site in Germany, or all of them as a file.
02

Study summary

Out-of-hospital cardiac arrest (OHCA) remains a major cause of mortality, with low survival probabilities to hospital discharge. Despite the frequent use of airway management and mechanical ventilation during resuscitation, there is limited evidence regarding the optimal ventilation strategy to improve oxygen delivery and patient outcomes. The present study aims to investigate the effects of positive-end-expiratory-pressure (PEEP) set at 5 mbar compared to zero-end-expiratory-pressure (ZEEP) on the return of spontaneous-circulation (ROSC) in adult patients with OHCA.

Read the detailed description

This is a prospective, multicenter, cluster-randomized controlled trial conducted across emergency medical services (EMS) in the regions of Guetersloh, Minden-Luebbecke and Osnabrueck. Adult patients (>= 18 years) with OHCA who are undergoing mechanical ventilation through an airway device will be enrolled. The clusters (regional district) will be randomized into two groups: one group will receive ventilation with PEEP set at 5 mbar (intervention group), while the other group will receive ventilation with ZEEP (control group). The study's primary endpoint is the rate of ROSC. Secondary endpoints include rate of re-arrest, death during pre-hospital care phase, hospital admission during ongoing resuscitation, hospital admission with spontaneous circulation, peripheral oxygen saturation and end tidal CO2 at hospital admission.

03

Conditions studied

  • Ventilation Therapy
  • PEEP, Occult
  • CPR
  • Cardiac Arrest (CA)

Browse trials for

Keywords

  • Cardiac Arrest
  • Positive End-Expiratory Pressure
  • Zero End-Expiratory Pressure
  • Ventilation
  • Randomized Controlled Trial
  • Emergency Medicine
  • Resuscitation
  • CPR
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults >= 18 years
  • non-traumatic OHCA
  • mechanical ventilation via airway device

Exclusion criteria

Exclusion Criteria:

  • Patients \< 18 years,
  • traumatic cause of OHCA,
  • no cardiac arrest, withholding of resuscitation (e.g. Do-Not-Resuscitate orders)
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
600 participants (estimated)

Study arms

  • Experimental
    PEEP

    PEEP Group (Intervention Group): Patients will receive mechanical ventilation with end-expiratory-pressure set at 5 mbar (PEEP).

    Procedure: PEEP 5 mbar

  • Experimental
    ZEEP

    ZEEP Group (Control Group): Patients will receive mechanical ventilation with end-expiratory-pressure set at 0 mbar (ZEEP).

    Procedure: ZEEP 0 mbar

Interventions

  • ProcedurePEEP 5 mbar

    Positiv-End-Expiratory Pressure

  • ProcedureZEEP 0 mbar

    Zero-End-Expiratory Pressure

06

What researchers measure

Primary outcomes

  1. The return of spontaneous circulation (ROSC)

    The primary outcome is the ROSC, defined according to the Utstein template by the presence of a palpable pulse during or after resuscitation. This will be measured as a binary outcome (palpable pulse, yes or no).

    Time frame: During or after resuscitation

Secondary outcomes

  1. Re-Arrest-Rate

    Any need for chest compressions after ROSC (yes vs. no)

    Time frame: Upon hospital admission

  2. Death during pre-hospital care phase

    Any death during pre-hospital care phase (yes vs. no)

    Time frame: Upon hospital admission

  3. Hospital admission during ongoing resuscitation

    Need for chest-compressions at hospital admission (yes vs. no)

    Time frame: at hospital admission

  4. Hospital admission with spontaneous circulation

    Hospital admission with spontaneous circulation without need for chest compressions (yes vs. no)

    Time frame: at hospital admission

  5. SpO2 at hospital admission

    SpO2 at hospital admission (%)

    Time frame: at hospital admission

  6. FiO2 at hospital admission

    FiO2 at hospital admission (%)

    Time frame: at hospital admission

07

Study locations

3 of 3 sites recruiting
  • Emergency Medical Services
    Gütersloh, North Rhine-Westphalia 33324, Germany
    Recruiting
  • JWK Minden
    Minden, North Rhine-Westphalia 32429, Germany
    Recruiting
    • Jochen Hinkelbein, MD · Contact
  • Emergency Medical Services
    Osnabrück, Germany
    Recruiting
08

References and documents

Publications

  • Vaseekaran M, Vollmer T, Kolaparambil Varghese LJ, Zeichen C, Hinkelbein J, Abels R, Strickmann B, Deicke M, Grannemann JJ, Grunzig R, Hoyer A, Persson J, Tiesmeier J, Veit G, Jansen G. Peri-arrest ventilation with positive end-expiratory-pressure vs. zero end-expiratory-pressure in out-of-hospital-cardiac-arrest (PerAVent)-a prospective, cluster-randomized multicenter trial. Trials. 2026 Jan 21;27(1):69. doi: 10.1186/s13063-025-09292-w. PubMed 41566395 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2025 (actual). Primary completion is estimated for Jun 2026, 12 months after the start.

Of 205 non-industry interventional studies with no phase under Heart Arrest, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 47. This study's planned 12 months is below that.

Counting every sponsor, half of 219 studies reached it within 28 months; a quarter within 10 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 21, 2025
First posted
Feb 20, 2025
StartActual
Jun 1, 2025
Primary completionEst.
Jun 30, 2026
CompletionEst.
Oct 31, 2026
Last update
Aug 6, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06836830
Lead sponsor
Muehlenkreiskliniken, MKK
Responsible party
Gerrit Jansen (Principal Investigator, Muehlenkreiskliniken, MKK) — Principal investigator
First posted
Feb 20, 2025
Start date
Jun 1, 2025
Primary completion
Jun 30, 2026 (estimated)
Completion
Oct 31, 2026 (estimated)
Last update
Aug 6, 2025

Study contacts

Gerrit Jansen, PD Dr. med.
Contact
gerrit.jansen@muehlenkreiskliniken.de
+49 571-790-54401
Jochen Hinkelbein, Prof. Dr. med.
Contact
jochen.hinkelbein@muehlenkreiskliniken.de
+49 571-790-54401

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion